Want to see JP:7071 full AI Analyst Report?
Top Page
Amvis Holdings.Inc.
(7071)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥372.00
▼(-21.52% Downside)
Action:Reiterated
Date:06/20/26
The score is held back primarily by deteriorating profitability and negative, worsening free cash flow alongside higher leverage. Technicals also indicate a clear downtrend (below major moving averages with negative MACD). Valuation is comparatively supportive (P/E 11.2 and 1.22% yield) but not enough to offset the financial and momentum risks.
Positive Factors
Consistent revenue growth
Sustained top-line growth shows the company is expanding service delivery and market reach in its core care segments. Over a multi-month horizon this underpins scale benefits, supports utilization improvement and provides a more stable revenue base to address margin and cash challenges if cost control follows.
Negative Factors
Declining profit margins
Substantial margin compression indicates structural pressure from higher costs or lower effective reimbursement. Persistently weaker gross and net margins erode operating leverage, reduce the ability to self-fund investments or service debt, and impair returns unless pricing or cost structures are materially improved.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue growth
Sustained top-line growth shows the company is expanding service delivery and market reach in its core care segments. Over a multi-month horizon this underpins scale benefits, supports utilization improvement and provides a more stable revenue base to address margin and cash challenges if cost control follows.
Read all positive factors
Amvis Holdings.Inc. (7071) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥35.20B
Dividend Yield0.91%
Average Volume (3M)1.46M
Price to Earnings (P/E)12.2
Beta (1Y)1.13
Revenue Growth9.10%
EPS Growth-54.63%
CountryJP
Employees5,135
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)26.19
Shares Outstanding98,313,600
10 Day Avg. Volume829,320
30 Day Avg. Volume1,455,976
Financial Highlights & Ratios
PEG Ratio-0.32
Price to Book (P/B)1.63
Price to Sales (P/S)1.19
P/FCF Ratio-13.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥385.50Price Target Upside-18.67% Downside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)25.07
Revenue Forecast (FY)¥51.35B
Amvis Holdings.Inc. Business Overview & Revenue Model
Company Description
Amvis Holdings, Inc. is a Japanese firm that delivers a wide array of care services. These offerings encompass residential nursing facilities, at-home nursing and general care, as well as various support programs for individuals with disabilities....
How the Company Makes Money
The company makes money primarily by earning service revenue from the provision of nursing care and related support services delivered through its operating subsidiaries. Revenue is generated when care is delivered to eligible users, with payments...
Amvis Holdings.Inc. Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.41B | 49.17B | 42.48B | 31.98B | 23.07B | 15.33B |
| Gross Profit | 10.62B | 14.79B | 17.05B | 13.26B | 9.67B | 6.29B |
| EBITDA | 7.08B | 9.02B | 12.76B | 10.39B | 7.12B | 4.49B |
| Net Income | 2.56B | 3.66B | 7.44B | 6.31B | 4.28B | 2.63B |
Balance Sheet | ||||||
| Total Assets | 83.92B | 84.16B | 71.99B | 55.69B | 41.85B | 31.99B |
| Cash, Cash Equivalents and Short-Term Investments | 9.21B | 10.83B | 8.87B | 12.13B | 11.34B | 11.19B |
| Total Debt | 38.37B | 40.15B | 31.75B | 23.05B | 17.43B | 12.75B |
| Total Liabilities | 45.98B | 48.02B | 38.77B | 29.17B | 21.39B | 15.65B |
| Stockholders Equity | 37.94B | 36.13B | 33.21B | 26.52B | 20.46B | 16.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.38B | -8.50B | -3.04B | -2.70B | -2.78B |
| Operating Cash Flow | 0.00 | 6.03B | 7.48B | 6.80B | 4.42B | 2.58B |
| Investing Cash Flow | 0.00 | -10.43B | -16.83B | -10.31B | -7.75B | -5.78B |
| Financing Cash Flow | 0.00 | 6.37B | 6.08B | 4.30B | 3.49B | 11.05B |
Amvis Holdings.Inc. Technical Analysis
Neutral
474.00
Price Trends
356.76
Negative
406.31
Negative
459.69
Negative
Market Momentum
1.35
Negative
52.86
Neutral
65.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7071, the sentiment is Neutral. The current price of 474 is above the 20-day moving average (MA) of 340.55, above the 50-day MA of 356.76, and above the 200-day MA of 459.69, indicating a neutral trend. The MACD of 1.35 indicates Negative momentum. The RSI at 52.86 is Neutral, neither overbought nor oversold. The STOCH value of 65.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7071.
Amvis Holdings.Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥45.95B | 15.65 | 20.80% | 1.77% | 14.79% | 20.14% | |
72 Outperform | ¥44.31B | 12.07 | ― | 2.63% | 3.49% | -14.24% | |
68 Neutral | ¥105.07B | 27.17 | ― | 2.47% | 2.70% | -5.16% | |
58 Neutral | ¥35.20B | 12.22 | ― | 0.91% | 9.10% | -54.63% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | ¥5.00B | 16.14 | ― | 1.41% | 16.83% | -45.33% |
* General Sector Average
JP:7071
Amvis Holdings.Inc.
356.00
-147.66
-29.32%
JP:6099
Elan Corp.
755.00
-46.46
-5.80%
JP:6062
Charm Care Corporation
1,350.00
67.88
5.29%
JP:6197
Solasto Corp.
1,109.00
693.35
166.81%
JP:7061
Japan Hospice Holdings Inc.
579.00
-448.89
-43.67%
Amvis Holdings.Inc. Corporate Events
Amvis Holds to Forecast as Profits Slide Despite Higher Sales
May 14, 2026
Amvis Holdings reported consolidated net sales of ¥25.6 billion for the six months ended March 31, 2026, up 7.5% year on year, but profitability deteriorated, with EBITDA down 11.5% and profit attributable to owners of parent falling 29.5% to...
Amvis Restores Full TSE Prime Compliance After Boosting Tradable Share Ratio
Apr 23, 2026
Amvis Holdings, Inc. has restored full compliance with all listing maintenance standards for the Tokyo Stock Exchange Prime Market after previously falling short on the tradable share ratio. The company reported that as of the end of March 2026, i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.